Back to top

Evercore ISI Sticks to Their Buy Rating for BioNTech SE (BNTX)

Evercore ISI analyst Cory Kasimov maintained a Buy rating on BioNTech SE yesterday and set a price target of $130.00. The company’s shares closed y...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioNTech SE Sponsored ADR (BNTX)